ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.775,62
2,35%
Brent Oil
83,76
0,67%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Imprimis Pharmaceuticals, Inc. (delisted) (IMMY)

  7. Imprimis Pharmaceuticals, Inc. (delisted) (IMMY) Notícias

IMMY

Imprimis Pharmaceuticals, Inc. (delisted) (IMMY)

Imprimis Pharmaceuticals, Inc. (delisted)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IMMY
DataHoraFonteTítuloCódigoCompanhia
30/04/201908:00GlobeNewswire Inc.ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual MeetingNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
12/03/201917:01GlobeNewswire Inc.Harrow Health Announces Fourth Quarter 2018 Financial ResultsNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
04/03/201909:00GlobeNewswire Inc.Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
28/02/201909:00GlobeNewswire Inc.Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
13/02/201910:00GlobeNewswire Inc.Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation FormulationsNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
07/02/201910:00GlobeNewswire Inc.Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
05/02/201910:00GlobeNewswire Inc.Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals SubsidiaryNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
03/01/201920:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
31/12/201810:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
31/12/201810:00GlobeNewswire Inc.Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
16/11/201810:30GlobeNewswire Inc.Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
13/11/201819:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
13/11/201819:01GlobeNewswire Inc.Imprimis Pharmaceuticals Announces Third Quarter 2018 ResultsNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
06/11/201810:00GlobeNewswire Inc.Imprimis Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 13, 2018NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
23/10/201808:00GlobeNewswire Inc.Imprimis Pharmaceuticals’ Subsidiary Melt Pharmaceuticals Initiates Clinical Development Program for its Patented Non-Opioi...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
16/10/201808:00GlobeNewswire Inc.ImprimisRx to feature new formulation and poster presentation on MKO Melt® at the upcoming American Academy of Ophthalmology...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
07/09/201818:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
06/08/201817:01PR Newswire (US)Imprimis Pharmaceuticals Announces Second Quarter 2018 ResultsNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
01/08/201808:30PR Newswire (US)Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection)...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
31/07/201808:30GlobeNewswire Inc.Imprimis Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 6, 2018NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
18/07/201808:30PR Newswire (US)Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
30/05/201808:30PR Newswire (US)ImprimisRx's Dropless® Steroid and Antibiotic Intravitreal Injection Featured in the Prestigious Journal of Cataract and Ref...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
15/05/201817:01PR Newswire (US)Imprimis Pharmaceuticals Announces First Quarter 2018 ResultsNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
15/05/201808:30PR Newswire (US)Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L PartnersNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
02/05/201808:30GlobeNewswire Inc.Imprimis Pharmaceuticals to Host its First Quarter 2018 Financial Report Conference Call and Webcast on May 15, 2018 at 4:30 ...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
30/04/201819:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
12/04/201817:39Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
10/04/201808:30PR Newswire (US)Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (m...NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
27/03/201808:30PR Newswire (US)Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation FormulationNASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
08/03/201818:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IMMYImprimis Pharmaceuticals, Inc. (delisted)
 Apresentando as notícias mais relevantes sobre:NASDAQ:IMMY

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GFSA3
GAFISA ON
BOV
HBOR3
HELBOR ON
BOV
OIBR3
OI ON
BOV
PRIO3
PETRORIO ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
ENAT3
ENAUTA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
AMAR3
LOJAS MARISA ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
MEAL3
IMC S/A ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
PDTC3
Padtec ON
BOV
AZEV4
AZEVEDO PN
BOV
OPCT3
Oceanpact Servicos Marit... ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados